Colgate's Share Repurchase Program - Analyst Blog
September 09 2011 - 2:06PM
Zacks
One of world's leading manufacturer of consumer products,
Colgate-Palmolive Company (CL) declared that its
board of directors has approved a new share repurchase program,
which reflects the company's sound financial position and
well-defined future prospects.
Under this program, the company will be authorized to repurchase
up to 50 million common share or approximately 10% of its
outstanding shares, either through open market or
privately-negotiated transactions over the next two-to-three years.
The company had approximately 486 million outstanding shares as of
June 30, 2011.
Colgate has always been committed to create value for its
shareholders by returning capital in the form of dividends and
share repurchase program. To improve shareholders' wealth, the
company will repurchase shares from time to time depending on
market conditions. These strategies will enhance shareholders'
return and lift the market value of the stock.
On August 15, 2011, Colgate paid a regular quarterly cash
dividend of 58 cents per share on its common shares, to
stockholders of record as of July 26, 2011. Since 1895, the company
has regularly paid cash dividend to its common shareholders.
Earlier, the company reported its second quarter 2011 quarterly
result. Colgate's earnings per share grew 7.7% to $1.26 a share
from $1.17 a share in the year-ago quarter. However, quarterly
earnings remain in line with the Zacks Consensus Estimate.
Global net sales increased 9.5% year over year to $4,185
million based on an increase of 0.5% in pricing and 6% rise in
foreign exchange coupled with a 3% addition from global unit
volume. On an organic basis (excluding foreign exchange,
acquisitions and divestitures), sales increased 3.5% in the
quarter. Global net sales beat the Zacks Consensus Revenue Estimate
of $4,159 million.
Colgate is expecting to achieve mid-single digit earnings per
share growth in fiscal 2011 with the help of the company's
aggressive growth initiatives coupled with strategic worldwide
pricing efforts. However, higher inflationary situation may lead to
a decline in gross margin in the range of 80 to 100 basis points
compared with fiscal 2010.
Colgate is the industry leader in oral care and commands
market-leading positions in many personal care product categories.
Furthermore, a strong portfolio of globally recognized brands,
including Colgate, Palmolive, Mennen, Softsoap, Irish Spring,
Protex, Sorriso, Kolynos, Elmex, Ajax and Axion provide a
competitive advantage to the company and strengthens its dominant
position in the market.
Colgate-Palmolive, which competes with Procter &
Gamble Company (PG) and Church & Dwight
Company Inc. (CHD), maintains a Zacks #3 Rank, which
translates into a short-term Hold recommendation. Our long-term
recommendation on the stock remains Neutral.
CHURCH & DWIGHT (CHD): Free Stock Analysis Report
COLGATE PALMOLI (CL): Free Stock Analysis Report
PROCTER & GAMBL (PG): Free Stock Analysis Report
Zacks Investment Research
Colgate Palmolive (NYSE:CL)
Historical Stock Chart
From May 2024 to Jun 2024
Colgate Palmolive (NYSE:CL)
Historical Stock Chart
From Jun 2023 to Jun 2024